Across TCGA pan-cancer cohorts, LINC02088 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated LINC02088 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher LINC02088 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02088 expression acts as an unfavorable survival marker, although some lineages such as SKCM and LUSC show a favorable association.

OV, CHOL, and MESO are the cancer types where LINC02088 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Tertile	III,IV	0.257	0.397	<.001	102	view →
CHOL	OS	Tertile	All	0.024	0.675	<.001	90	view →
MESO	OS	Tertile	II,III,IV	0.392	0.579	.013	90	view →
LIHC	OS	Tertile	All	0.457	0.716	<.001	78	view →
KIRC	DFS	Tertile	II,III,IV	0.229	0.544	.003	48	view →
COAD	DFS	Tertile	IV	0.139	0.513	<.001	42	view →
SKCM	OS	Tertile	All	0.861	0.761	.005	39	view →
KIRP	DFS	Tertile	IV	0.162	0.546	.009	36	view →
READ	OS	Tertile	IV	0.289	0.899	<.001	30	view →
DLBC	DFS	Tertile	All	0.357	0.861	.002	30	view →
LUSC	DFS	Tertile	III,IV	0.768	0.305	.007	24	view →
UVM	DFS	Tertile	III,IV	0.328	0.631	.015	24	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

Exploration

Same gene, other analysis: LINC02088 tumor-vs-normal RNA expression · all LINC02088 data types